PREDICTING FAVOURABLE PATHOLOGICAL OUTCOME IN PATIENTS WITH CLINICAL HIGH RISK PROSTATE CANCER. A NOVEL NOMOGRAM BASED ON A MULTI-INSTITUTIONAL ANALYSIS

被引：0
|
作者：
Briganti, Alberto
Spahn, Martin
Joniau, Steven
Gontero, Paolo
Montorsi, Francesco
Marchioro, Giansilvio
Tombal, Bertrand
Frohneberg, Detlef
Isbarn, Hendrik
Bangma, Chris
Schroeder, Fritz
Kneitz, Burkhard
Bader, Pia
Graefen, Markus
Tizzani, Alessandro
Van Poppel, Hendrik
机构：
来源：
JOURNAL OF UROLOGY | 2010年 / 183卷 / 04期
关键词：
D O I：
10.1016/j.juro.2010.02.1317
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
1552
引用
收藏
页码：E599 / E599
页数：1
相关论文
共 50 条
  • [41] Predicting prostate cancer-specific outcome after radical prostatectomy among men with very high-risk cT3b/4 PCa: a multi-institutional outcome study of 266 patients
    Moltzahn, F.
    Karnes, J.
    Gontero, P.
    Kneitz, B.
    Tombal, B.
    Bader, P.
    Briganti, A.
    Montorsi, F.
    Van Poppel, H.
    Joniau, S.
    Spahn, M.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2015, 18 (01) : 31 - 37
  • [42] Radiotherapy at oligoprogression for metastatic castration-resistant prostate cancer patients: a multi-institutional analysis
    Maurizio Valeriani
    Beatrice Detti
    Andrei Fodor
    Saverio Caini
    Simona Borghesi
    Fabio Trippa
    Luca Triggiani
    Alessio Bruni
    Donatella Russo
    Simonetta Saldi
    Mario Di Staso
    Giulio Francolini
    Andrea Lancia
    Luca Marinelli
    Nadia Di Muzio
    Cynthia Aristei
    Lorenzo Livi
    Stefano Maria Magrini
    Gianluca Ingrosso
    La radiologia medica, 2022, 127 : 108 - 116
  • [43] Outcome predictors of radical cystectomy in patients with cT4 prostate cancer: a multi-institutional study of 62 patients
    Spahn, Martin
    Morlacco, Alessandro
    Boxler, Silvan
    Joniau, Steven
    Briganti, Alberto
    Montorsi, Francesco
    Gontero, Paolo
    Bader, Pia
    Frohneberg, Detlef
    van Poppel, Hein
    Karnes, Robert Jeffrey
    BJU INTERNATIONAL, 2017, 120 (5B) : E52 - E58
  • [44] Radiotherapy at oligoprogression for metastatic castration-resistant prostate cancer patients: a multi-institutional analysis
    Valeriani, Maurizio
    Detti, Beatrice
    Fodor, Andrei
    Caini, Saverio
    Borghesi, Simona
    Trippa, Fabio
    Triggiani, Luca
    Bruni, Alessio
    Russo, Donatella
    Saldi, Simonetta
    Di Staso, Mario
    Francolini, Giulio
    Lancia, Andrea
    Marinelli, Luca
    Di Muzio, Nadia
    Aristei, Cynthia
    Livi, Lorenzo
    Magrini, Stefano Maria
    Ingrosso, Gianluca
    RADIOLOGIA MEDICA, 2022, 127 (01): : 108 - 116
  • [45] Validation of a genomic-clinical classifier for predicting clinical progression in high-risk prostate cancer.
    Buerki, Christine
    Mitra, Anirban Pradip
    Black, Peter C.
    Ghadessi, Mercedeh
    Bergstralh, Eric J.
    Erho, Nicholas
    Carlson, Rachel
    Crisan, Anamaria
    Sierocinski, Thomas
    Zimmermann, Benedikt
    Haddad, Zaid
    Vergara, Ismael A.
    Ballman, Karla V.
    Klee, George G.
    Fink, Stephanie
    Kollmeyer, Thomas M.
    Triche, Timothy J.
    Davicioni, Elai
    Karnes, R. Jeffrey
    Jenkins, Robert B.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [46] Re: Adjuvant weekly docetaxel for patients with high risk prostate cancer after radical prostatectomy: A multi-institutional pilot study
    Kibel, A. S.
    Rosenbaum, E.
    Kattan, M. W.
    Picus, J.
    Dreicer, R.
    Klein, E. A.
    Chatta, G. S.
    Nelson, J. B.
    DiPaola, R. S.
    Roth, B. J.
    Cookson, M. S.
    Wilding, G.
    Jarrard, D. F.
    Beer, T. M.
    Ryan, C. W.
    Petrylak, D. P.
    Benson, M. C.
    Partin, A. W.
    Garrett-Mayer, E.
    Eisenberger, M. A.
    Raghavan, Derek
    EUROPEAN UROLOGY, 2007, 52 (05) : 1530 - 1531
  • [47] Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer - A multi-institutional update
    Partin, AW
    Kattan, MW
    Subong, EN
    Walsh, PC
    Wojno, KJ
    Oesterling, JE
    Scardino, PT
    Pearson, JD
    Graefen, M
    AKTUELLE UROLOGIE, 2004, 35 (05) : 377 - 378
  • [48] Combination of prostate-specific antigen, clinical stage, and gleason score to predict pathological stage of localized prostate cancer - A multi-institutional update
    Partin, AW
    Kattan, MW
    Subong, ENP
    Walsh, PC
    Wojno, KJ
    Oesterling, JE
    Scardino, PT
    Pearson, JD
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (18): : 1445 - 1451
  • [49] External-beam radiotherapy for localized or locally advanced prostate cancer in Japan: A multi-institutional outcome analysis
    Nakamura, Katsumasa
    Mizowaki, Takashi
    Imada, Hajime
    Karasawa, Katsuyuki
    Uno, Takashi
    Onishi, Hiroshi
    Nihei, Keiji
    Sasaki, Shigeru
    Ogura, Masakazu
    Akimoto, Tetsuo
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2008, 38 (03) : 200 - 204
  • [50] INCORPORATING PROSTATE MRI IMAGING CHARACTERISTICS TO IMPROVE PROSTATE CANCER DIAGNOSIS AND RISK STRATIFICATION: AN ANALYSIS AND NOMOGRAM DERIVED FROM A 9,536 PATIENT, MULTI-INSTITUTIONAL COHORT
    Shumaker, Luke A. R.
    Fang, Andrew
    Kaneko, Masatomo
    Ramacciotti, Lorenzo
    Prakash, Nachiketh
    Das, Arighno
    Patel, Hiten
    Khajir, Ghazal
    Fan, Richard
    Wang, Shu
    Pineault, Kevin
    Sidana, Abhinav
    Gupta, Gopal
    Filson, Christopher
    Wysock, James
    Siddiqui, M. Minhaj
    Sonn, Geoffrey A.
    Sprenkle, Preston
    Ross, Ashley
    Jarrard, David
    Punnen, Sanoj
    Abreu, Andre
    Rais-Bahrami, Soroush
    JOURNAL OF UROLOGY, 2024, 211 (05): : E316 - E317
12345